Trump meets Zelenskiy, says Putin wants war to end, mulls trilateral talks
LEHI, Utah - Nature’s Sunshine Products, Inc. (NASDAQ:NATR) reported mixed fourth quarter results, with revenue beating expectations but earnings per share falling short of estimates. The company’s stock edged up 0.69% following the release.
The herbal and nutritional supplements manufacturer posted Q4 revenue of $118.2 million, up 8.5% year-over-year and surpassing the analyst consensus of $109.46 million. However, adjusted earnings per share came in at $0.00, missing the $0.20 estimate.
For the full year 2024, Nature’s Sunshine reported net sales of $454.4 million, a 2% increase from 2023. Adjusted EBITDA rose slightly to $40.5 million compared to $40.4 million in the prior year.
"The fourth quarter was one of our strongest quarters ever, with revenue of $118 million, reflecting growth of 8.5% year-over-year and 10% on a constant currency basis," said CEO Terrence Moorehead. He highlighted 21% growth in Asia Pacific and continued execution of strategies in Europe as key drivers.
Looking ahead, Nature’s Sunshine provided full year 2025 revenue guidance of $445-470 million, compared to the consensus estimate of $457.1 million.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.